本页面由Tiger Trade Technology Pte. Ltd.提供服务

Compugen医疗

1.98
-0.0900-4.35%
盘后:2.010.0300+1.52%19:30 EDT
成交量:22.36万
成交额:45.36万
市值:1.87亿
市盈率:5.30
高:2.09
开:2.09
低:1.96
收:2.07
52周最高:3.24
52周最低:1.43
股本:9,455.41万
流通股本:9,245.75万
量比:1.22
换手率:0.24%
股息:- -
股息率:- -
每股收益(TTM):0.3733
每股收益(LYR):0.3783
净资产收益率:50.64%
总资产收益率:15.46%
市净率:2.11
市盈率(LYR):5.23

数据加载中...

2026/07/29

SEC问询函

Form CORRESP - Correspondence
2026/06/05

SEC问询函

Form CORRESP - Correspondence
2026/04/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/03/04

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/05

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/08/23

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2023/08/23

SEC问询函

Form CORRESP - Correspondence
2023/06/23

SEC问询函

Form CORRESP - Correspondence
2023/04/14

SEC问询函

Form CORRESP - Correspondence
2023/02/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/08/04

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans